Waters Corp

$425.21$0.00 (+0.00%)
Last updated on --.

Waters Corp price

24 Hours+0.00%$0.00
30 days+3.87%+$15.83
60 days+6.38%+$25.51
90 days+13.41%+$50.28

About Waters Corp

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

Stock ticker
WAT
Company
Waters Corporation
Industry
Healthcare
Category
US
Stock split / reverse split
12
Launch date
Nov 17, 1995
Listed exchange
NYSE

Financials

Q2 FY2026 Earnings
Report period: Apr 5, 2026 – Jul 4, 2026

Summary: WAT reported Revenue of 1.65B (+113.27%), beating expectations; EPS of 3.05 (+3.39%), beating expectations.

Revenue (USD)Beat1.65B+113.26%1.62B+116.69%22.70M+1.39%
EPS (USD)Beat3.05+3.38%3.01+2.38%0.04+1.32%
Financial estimates
● Actual● Estimate
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
2.472.503.77-0.87-1.39
+2.91%-7.75%-2.84%-142.86%-156.28%
● EPS● YoY
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
4.72B4.86B5.08B24.53B24.75B
2.56B2.53B2.52B9.24B9.56B
54.22%52.06%49.54%37.66%38.60%
● Assets● Liabilities● Ratio
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
41.14M187.31M164.55M-3.00M201.00M
-24.56%-8.45%-31.48%-101.16%+388.56%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.8.64%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
STATE STREET CORP5.33%
VANGUARD PORTFOLIO MANAGEMENT LLC4.82%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/4.70%
Others69.95%
Institutions
% Owned120.27%+4.76%
Shares held98.79M+3.92M
Institutions1,202+10
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.8.64%-58.08K
VANGUARD CAPITAL MANAGEMENT LLC6.53%+36.78K
STATE STREET CORP5.33%+20.00K
VANGUARD PORTFOLIO MANAGEMENT LLC4.82%-13.66K
MASSACHUSETTS FINANCIAL SERVICES CO /MA/4.70%-5.08K

Dividends

Dividends
Last ex-dividend: Nov 26, 1996 Cash dividend: 0.16 USD per share
Dividend yield TTM
--
Payout ratio LFY
0.00%
Frequency
--
1996
0.04
+0.59%
Dividend amount (USD)Dividend yield
Stock splits
Launch date: Nov 17, 1995
DateRatio
Aug 28, 20001 → 2
Jun 11, 19991 → 2

Waters Corp conversion tables

WATWAT
USDUSD
0.5 WAT212.6 USD
1 WAT425.21 USD
5 WAT2,126.05 USD
10 WAT4,252.1 USD
USDUSD
WATWAT
0.5 USD0.0011759 WAT
1 USD0.0023518 WAT
5 USD0.011759 WAT
10 USD0.023518 WAT

More to explore

FAQ

WAT is trading at $425.21, +0.00% over the last 24 hours. Track live moves on the price chart at the top of this page.

The WAT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. WAT is currently trading at $425.21, +0.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on WAT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. WAT's P/E ratio is currently 106.04 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from WAT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against WAT's historical range and other companies in the Healthcare sector.

Waters Corporation's market cap is currently 41.75B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.